Jim Cramer Finds Pfizer (PFE)'s Stock Level "Unfathomable"
Jim Cramer has discussed pharma giant Pfizer Inc. (NYSE:PFE) several times recently.
Pfizer Inc (PFE)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 49,288,054 | $1,255,859,657 | +2% | 0.45% |
| 2. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 18,565,451 | $473,047,691 | -1% | 0.3% |
| 3. | 14,500,500 | $369,472,740 | -10% | 0.06% | |
| 4. | Unisphere Establishment Hani Lazkani (Ceo) | 14,400,000 | $366,912,000 | +14% | 2.88% |
| 5. | Diamond Hill Capital Ric Dillon | 10,924,267 | $278,350,323 | -39% | 1.32% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.65 | 19,457 | $499,072.05 | 27,707 | 2025-02-13 | Filing | |
| $28.24 | 1,000 | $28,240.00 | 10,000 | 2024-10-30 | Filing | |
| $26.47 | 3,000 | $79,401.00 | 9,000 | 2023-12-15 | Filing | |
| $38.58 | 1,000 | $38,580.00 | 6,000 | 2023-05-08 | Filing | |
| $38.43 | 1,000 | $38,425.00 | 5,000 | 2023-05-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.93 | 2,500 | $64,825.00 | 11,850 | 2025-03-04 | Filing | |
| $28.66 | 5,154 | $147,713.64 | 8,582 | 2024-08-13 | Filing | |
| $40.02 | 9,912 | $396,678.24 | 9,003 | 2023-03-15 | Filing | |
| $53.96 | 4,218 | $227,603.28 | 10,846 | 2022-06-07 | Filing | |
| $50.50 | 4,000 | $202,000.00 | 15,064 | 2022-05-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 534,315,020 | $13,614,346,712 | 0.2% | |
| 2. | 497,434,544 | $12,674,632,188 | 0.22% | |
| 3. | 299,087,408 | $7,620,747,156 | 0.26% | |
| 4. | 129,007,353 | $3,279,040,507 | 0.21% | |
| 5. | 74,770,658 | $1,905,156,415 | 0.12% |
News See All
TD Cowen Maintains a Hold on Pfizer Inc. (PFE) With a $30 PT
Pfizer Inc. (NYSE:PFE) is one of the best undervalued stocks to buy under $50. Pfizer Inc.
Jim Cramer Offered Insights on These 16 Stocks
“So it was the government shutdown and some insane comments from OpenAI about a government backstop because of gigantic spending that caused the sell-off.
14 Best Undervalued Stocks to Buy Under $50
He stated that since the beginning of the year, the market has been very bifurcated, not just in terms of performance but also in terms of earnings and profit margins.
12 Latest Stocks on Jim Cramer's Radar
In his latest appearance on CNBC's Squawk on the Street, Jim Cramer discussed the government shutdown and air traffic controllers.
"Pfizer (PFE) Beat The Numbers And People Just Yawned," Says Jim Cramer
Pfizer Inc. (NYSE:PFE) reported its third-quarter earnings report yesterday.
Jim Cramer Answered Harvard Business School Students' Questions: 9 Stocks in Focus
“A reminder once again that we all too often celebrate those who got it right for a day, betting against tremendous companies instead of celebrating those who got it right by owning and hitching their...
9 Latest Stocks on Jim Cramer’s Radar
On Tuesday, Mad Money host Jim Cramer said that Wall Street has become too obsessed with the massive valuations of certain technology and speculative stocks.
10 Stocks Jim Cramer Discussed Including His Palantir Deep Dive
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the overall dim sentiment at the market's open and wondered whether it was related to the data analytics firm, Palantir.
Pfizer Inc. (NYSE:PFE) Q3 2025 Earnings Call Transcript
Operator: Good day, everyone, and welcome to Pfizer's Third Quarter 2025 Earnings Conference Call. Today's call is being recorded.